Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia?
Wiesfeld
A C P
AC
Ansink
J M
JM
van Veldhuisen
D J
DJ
van Gelder
I C
IC
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000494:pharmacology; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D001282:Atrial Flutter; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008790:Metoprolol / Q000008:administration & dosage / Q000494:pharmacology; D008875:Middle Aged; D011405:Propafenone / Q000009:adverse effects* / Q000494:pharmacology; D013617:Tachycardia, Supraventricular / Q000139:chemically induced*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D011405:Propafenone; D008790:Metoprolol